Medicines Co $26.17

up +0.08


27/8/2014 04:00 PM  |  NASDAQ : MDCO  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get MDCO Trend Analysis - it has underperformed the S&P 500 by 39%

Partner Headlines

  1. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  2. Benzinga's Top Downgrades

    Benzinga
  3. Benzinga's Top Downgrades

    Benzinga
  4. Medicines Co.

    IBD
  5. Mid-Afternoon Market Update: Compuware Holds Onto Gains, Clearwire Remains ...

    Benzinga
  6. Stocks Higher In Afternoon; Thor Industires Jumps

    IBD
  7. Mid-Day Market Update: Verint Shares Jump On Upbeat Results; Medicines ...

    Benzinga
  8. Medicines Co. Down On Setback In Hospira Patent Case

    IBD
  9. Stocks Hitting 52-Week Lows

    Benzinga
  10. Mid-Morning Market Update: Markets Gain; Ford March Sales Rise 3%

    Benzinga
  11. Morning Market Losers

    Benzinga
  12. Benzinga's Top #PreMarket Losers

    Benzinga
  13. Medicines Co. earnings miss

    IBD
  14. Earnings Scheduled For February 19, 2014

    Benzinga
  15. FDA nixes Medicines' drug

    IBD
  16. Mid-Afternoon Market Update: Market Rally Levels Out As Time Warner/Comcast ...

    Benzinga
  17. Mid-Day Market Update: U.S. Stocks Rise; Orbitz Shares Surge On Upbeat ...

    Benzinga
  18. Medicines Co. Downgraded After FDA Panel Rejects Drug

    IBD
  19. Mid-Morning Market Update: Markets Drop; Comcast To Acquire Time Warner ...

    Benzinga
  20. Stocks Hitting 52-Week Lows

    Benzinga
  21. UPDATE: Credit Suisse Downgrades The Medicines Company Following Negative ...

    Benzinga
  22. Benzinga's Top #PreMarket Losers

    Benzinga
  23. UPDATE: The Medicines Co. Reminds Investors of FDA CRDAC Meeting Today, ...

    Benzinga
  24. Mid-Afternoon Market Update: Red Robin Continues to Rally as The Medicines ...

    Benzinga
  25. Leaders Hold Near Buy Points Despite Monday Sell-Off

    IBD
  26. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  27. Scanning Leading Stocks For Earnings Growth In 2014

    IBD
  28. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  29. Medicines acquires Rempex

    IBD
  30. Benzinga's M&A Chatter for Wednesday December 4, 2013

    Benzinga
  31. Medicines Co. Acquires Rempex Pharma; Street Applauds

    IBD
  32. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga
  33. Five Medical Stocks Leaders Trade Near New Highs

    IBD
  34. A Few Stocks Form Bases, But Have Flaws

    IBD
  35. Strong Pipeline Expected To Drive Growth At Medicines Co.

    IBD
  36. Medicines Co. Mostly Steady After Low-Volume Breakout

    IBD
  37. ViroPharma Gets Bought Out; Medicines Clears Entry

    IBD
  38. Santarus Earnings Should Top 4 Hot Small-Cap Medicals

    IBD
  39. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  40. LinkedIn, Alliance Fiber Lead Q3 Young Gun Earnings

    IBD
  41. Medicines Co. In Late Stages Of Base Formation

    IBD
  42. Medicines Co. sales topped

    IBD
  43. Medicines Co. Reports Mixed Q3 As New Products Await

    IBD
  44. Medicines Co. Sales Beat Estimates As Angiomax Grows

    IBD
  45. UPDATE: Leerink Swann Raises PT on The Medicines Company Following Analyst ...

    Benzinga
  46. The Medicines Company, Alnylam Announce Advance Development Candidate ...

    Benzinga
  47. The Medicines Company's Publishes Phase III Data from Trials of IV Cangrelor

    Benzinga
  48. UPDATE: Bank of America Upgrades Medicines Company on Leverage

    Benzinga
  49. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  50. The Medicines Company Announces Proposed Public Offering of 5.5 Million ...

    Benzinga
Trading Center